Cited by 245

The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.

Caloric restriction mimetics: towards a molecular definition

Madeo, Frank, Pietrocola, Federico, Eisenberg, Tobias, Kroemer, Guido·2014·Nature Reviews Drug Discovery

Abstract

Caloric restriction, be it constant or intermittent, is reputed to have health-promoting and lifespan-extending effects. Caloric restriction mimetics (CRMs) are compounds that mimic the biochemical and functional effects of caloric restriction. In this Opinion article, we propose a unifying definition of CRMs as compounds that stimulate autophagy by favouring the deacetylation of cellular proteins. This deacetylation process can be achieved by three classes of compounds that deplete acetyl coenzyme A (AcCoA; the sole donor of acetyl groups), that inhibit acetyl transferases (a group of enzymes that acetylate lysine residues in an array of proteins) or that stimulate the activity of deacetylases and hence reverse the action of acetyl transferases. A unifying definition of CRMs will be important for the continued development of this class of therapeutic agents.

Overview

Integrity signals

Registry

Crossref · 10.1038/nrd4391

Cites

36 of 36 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • S-nitrosylation, the covalent binding of nitric oxide to specific cysteine residues, is a mechanism through which autophagy-related proteins are regulated.

    “Another mechanism through which autophagy-related proteins are regulated is by means of S-nitrosylation, the covalent binding of nitric oxide (NO) to specific cysteine residues [1003].”

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 167

  1. Rubinsztein, D. C., Mariño, G. & Kroemer, G. Autophagy and aging. Cell 146, 682–695 (2011). · DOI · Paper page
  2. Libert, S. & Guarente, L. Metabolic and neuropsychiatric effects of calorie restriction and sirtuins. Annu. Rev. Physiol. 75, 669–684 (2013). · DOI
  3. Colman, R. J. et al. Caloric restriction delays disease onset and mortality in rhesus monkeys. Science 325, 201–204 (2009). · DOI · Paper page
  4. Anson, R. M. et al. Intermittent fasting dissociates beneficial effects of dietary restriction on glucose metabolism and neuronal resistance to injury from calorie intake. Proc. Natl Acad. Sci. USA 100, 6216–6220 (2003). · DOI
  5. Klempel, M. C., Kroeger, C. M., Bhutani, S., Trepanowski, J. F. & Varady, K. A. Intermittent fasting combined with calorie restriction is effective for weight loss and cardio-protection in obese women. Nutr. J. 11, 4 (2012). · DOI
  6. Magkos, F., Yannakoulia, M., Chan, J. L. & Mantzoros, C. S. Management of the metabolic syndrome and type 2 diabetes through lifestyle modification. Annu. Rev. Nutr. 29, 223–256 (2009). · DOI
  7. Roth, L. W. & Polotsky, A. J. Can we live longer by eating less? A review of caloric restriction and longevity. Maturitas 71, 315–319 (2012). · DOI
  8. Choi, A. M. K., Ryter, S. W. & Levine, B. Autophagy in human health and disease. N. Engl. J. Med. 368, 1845–1846 (2013). · DOI · Paper page
  9. Eisenberg, T. et al. Nucleocytosolic depletion of the energy metabolite acetyl-coenzyme a stimulates autophagy and prolongs lifespan. Cell. Metab. 19, 431–444 (2014). · DOI · Paper page
  10. Lum, J. J. et al. Growth factor regulation of autophagy and cell survival in the absence of apoptosis. Cell 120, 237–248 (2005). · DOI · Paper page
  11. Boya, P. et al. Inhibition of macroautophagy triggers apoptosis. Mol. Cell. Biol. 25, 1025–1040 (2005). · DOI
  12. Meléndez, A. et al. Autophagy genes are essential for dauer development and life-span extension in C. elegans. Science 301, 1387–1391 (2003). · DOI · Paper page
  13. Pietrocola, F. et al. Pro-autophagic polyphenols reduce the acetylation of cytoplasmic proteins. Cell Cycle 11, 3851–3860 (2012). · DOI
  14. Wellen, K. E. & Thompson, C. B. A two-way street: reciprocal regulation of metabolism and signalling. Nature Rev. Mol. Cell. Biol. 13, 270–276 (2012). · DOI · Paper page
  15. Yeh, L. A. & Kim, K. H. Regulation of acetyl-coA carboxylase: properties of coA activation of acetyl-coA carboxylase. Proc. Natl Acad. Sci. USA 77, 3351–3355 (1980). · DOI
  16. Imamura, H. et al. Visualization of ATP levels inside single living cells with fluorescence resonance energy transfer-based genetically encoded indicators. Proc. Natl Acad. Sci. USA 106, 15651–15656 (2009). · DOI
  17. Weinert, B. T. et al. Acetylation dynamics and stoichiometry in Saccharomyces cerevisiae. Mol. Syst. Biol. 10, 716 (2014). · DOI
  18. Takahashi, H., McCaffery, J. M., Irizarry, R. A. & Boeke, J. D. Nucleocytosolic acetyl-coenzyme a synthetase is required for histone acetylation and global transcription. Mol. Cell 23, 207–217 (2006). · DOI · Paper page
  19. Roberts, D. J., Tan-Sah, V. P., Ding, E. Y., Smith, J. M. & Miyamoto, S. Hexokinase-II positively regulates glucose starvation-induced autophagy through TORC1 inhibition. Mol. Cell 53, 521–533 (2014). · DOI
  20. Mohanti, B. K. et al. Improving cancer radiotherapy with 2-deoxy-D-glucose: Phase I/II clinical trials on human cerebral gliomas. Int. J. Radiat. Oncol. Biol. Phys. 35, 103–111 (1996). · DOI
  21. Mariño, G. et al. Autophagy is essential for mouse sense of balance. J. Clin. Invest. 120, 2331–2344 (2010). · DOI
  22. Onakpoya, I., Hung, S. K., Perry, R., Wider, B. & Ernst, E. The use of garcinia extract (hydroxycitric acid) as a weight loss supplement: a systematic review and meta-analysis of randomised clinical trials. J. Obes. 2011, 509038 (2011). · DOI
  23. Saito, M. et al. High dose of Garcinia cambogia is effective in suppressing fat accumulation in developing male Zucker obese rats, but highly toxic to the testis. Food Chem. Toxicol. 43, 411–419 (2005). · DOI
  24. Haberland, M., Montgomery, R. L. & Olson, E. N. The many roles of histone deacetylases in development and physiology: implications for disease and therapy. Nature Rev. Genet. 10, 32–42 (2009). · DOI
  25. Wang, Q. et al. Acetylation of metabolic enzymes coordinates carbon source utilization and metabolic flux. Science 327, 1004–1007 (2010). · DOI · Paper page
  26. Zhao, S. et al. Regulation of cellular metabolism by protein lysine acetylation. Science 327, 1000–1004 (2010). · DOI · Paper page
  27. Alavez, S., Vantipalli, M. C., Zucker, D. J. S., Klang, I. M. & Lithgow, G. J. Amyloid-binding compounds maintain protein homeostasis during ageing and extend lifespan. Nature 472, 226–229 (2011). · DOI · Paper page
  28. Soh, J.-W. et al. Curcumin is an early-acting stage-specific inducer of extended functional longevity in Drosophila. Exp. Gerontol. 48, 229–239 (2013). · DOI
  29. Bjedov, I. et al. Mechanisms of life span extension by rapamycin in the fruit fly Drosophila melanogaster. Cell. Metab. 11, 35–46 (2010). · DOI · Paper page
  30. Abbas, S. & Wink, M. Epigallocatechin gallate from green tea (Camellia sinensis) increases lifespan and stress resistance in Caenorhabditis elegans. Planta Med. 75, 216–221 (2009). · DOI
  31. Zhang, L., Jie, G., Zhang, J. & Zhao, B. Significant longevity-extending effects of EGCG on Caenorhabditis elegans under stress. Free Radic. Biol. Med. 46, 414–421 (2009). · DOI
  32. Niu, Y. et al. The phytochemical, EGCG, extends lifespan by reducing liver and kidney function damage and improving age-associated inflammation and oxidative stress in healthy rats. Aging Cell 12, 1041–1049 (2013). · DOI
  33. Choi, Y. B., Kim, Y. I., Lee, K. S., Kim, B. S. & Kim, D. J. Protective effect of epigallocatechin gallate on brain damage after transient middle cerebral artery occlusion in rats. Brain Res. 1019, 47–54 (2004). · DOI
  34. Koh, S.-H. et al. The effect of epigallocatechin gallate on suppressing disease progression of ALS model mice. Neurosci. Lett. 395, 103–107 (2006). · DOI
  35. Zhou, J. et al. Epigallocatechin-3-gallate (EGCG), a green tea polyphenol, stimulates hepatic autophagy and lipid clearance. PLoS ONE 9, e87161 (2014). · DOI
  36. Gupta, S. C., Kismali, G. & Aggarwal, B. B. Curcumin, a component of turmeric: from farm to pharmacy. BioFactors 39, 2–13 (2013). · DOI
  37. Kim, H.-S., Quon, M. J. & Kim, J.-A. New insights into the mechanisms of polyphenols beyond antioxidant properties; lessons from the green tea polyphenol, epigallocatechin 3-gallate. Redox Biol. 2, 187–195 (2014). · DOI · Paper page
  38. Morselli, E. et al. Spermidine and resveratrol induce autophagy by distinct pathways converging on the acetylproteome. J. Cell Biol. 192, 615–629 (2011). · DOI
  39. Bauer, M. A. et al. Spermidine promotes mating and fertilization efficiency in model organisms. Cell Cycle 12, 346–352 (2013). · DOI
  40. Soda, K. et al. Long-term oral polyamine intake increases blood polyamine concentrations. J. Nutr. Sci. Vitaminol. 55, 361–366 (2009). · DOI
  41. Gupta, V. K. et al. Restoring polyamines protects from age-induced memory impairment in an autophagy-dependent manner. Nature Neurosci. 16, 1453–1460 (2013). · DOI
  42. Kibe, R. et al. Upregulation of colonic luminal polyamines produced by intestinal microbiota delays senescence in mice. Sci. Rep. 4, 4548 (2014). · DOI
  43. Soda, K., Kano, Y., Chiba, F., Koizumi, K. & Miyaki, Y. Increased polyamine intake inhibits age-associated alteration in global DNA methylation and 1,2-dimethylhydrazine-induced tumorigenesis. PLoS ONE 8, e64357 (2013). · DOI
  44. Goodwin, A. C. et al. Polyamine catabolism contributes to enterotoxigenic Bacteroides fragilis-induced colon tumorigenesis. Proc. Natl Acad. Sci. USA 108, 15354–15359 (2011). · DOI · Paper page
  45. LaRocca, T. J., Gioscia-Ryan, R. A., Hearon Jr., C. M. & Seals, D. R. The autophagy enhancer spermidine reverses arterial aging. Mech. Ageing Dev. 134, 314–320 (2013). · DOI
  46. Paul, S. & Kang, S. C. Natural polyamine inhibits mouse skin inflammation and macrophage activation. Inflamm. Res. 62, 681–688 (2013). · DOI
  47. Soda, K., Dobashi, Y., Kano, Y., Tsujinaka, S. & Konishi, F. Polyamine-rich food decreases age-associated pathology and mortality in aged mice. Exp. Gerontol. 44, 727–732 (2009). · DOI · Paper page
  48. Miller, R. A. et al. An Aging Interventions Testing Program: study design and interim report. Aging Cell 6, 565–575 (2007). · DOI · Paper page
  49. Nadon, N. L. et al. Design of aging intervention studies: the NIA interventions testing program. Age 30, 187–199 (2008). · DOI · Paper page
  50. Lee, I. H. & Finkel, T. Regulation of autophagy by the p300 acetyltransferase. J. Biol. Chem. 284, 6322–6328 (2009). · DOI · Paper page
  51. Nakagawa, Y. et al. p300 plays a critical role in maintaining cardiac mitochondrial function and cell survival in postnatal hearts. Circ. Res. 105, 746–754 (2009). · DOI
  52. Mackeh, R. et al. Reactive oxygen species, AMP-activated protein kinase and the transcription cofactor p300 regulate α-tubulin acetyltransferase-1 (αTAT-1/MEC-17)-dependent microtubule hyperacetylation during cell stress. J. Biol. Chem. 289, 11816–11828 (2014). · DOI
  53. Sebti, S. et al. BAT3 modulates p300-dependent acetylation of p53 and autophagy-related protein 7 (ATG7) during autophagy. Proc. Natl Acad. Sci. USA 111, 4115–4120 (2014). · DOI
  54. Devipriya, B. & Kumaradhas, P. Probing the effect of intermolecular interaction and understanding the electrostatic moments of anacardic acid in the active site of p300 enzyme via DFT and charge density analysis. J. Mol. Graph. Model. 34, 57–66 (2012). · DOI
  55. Seong, Y.-A., Shin, P.-G., Yoon, J.-S., Yadunandam, A. K. & Kim, G.-D. Induction of the endoplasmic reticulum stress and autophagy in human lung carcinoma a549 cells by anacardic acid. Cell Biochem. Biophys. 68, 369–377 (2014). · DOI
  56. Lin, S.-Y. et al. GSK3-TIP60-ULK1 signaling pathway links growth factor deprivation to autophagy. Science 336, 477–481 (2012). · DOI · Paper page
  57. Balasubramanyam, K. et al. Polyisoprenylated benzophenone, garcinol, a natural histone acetyltransferase inhibitor, represses chromatin transcription and alters global gene expression. J. Biol. Chem. 279, 33716–33726 (2004). · DOI
  58. Chen, X. et al. Chemoprevention of 7,12-dimethylbenz[a]anthracene (DMBA)-induced hamster cheek pouch carcinogenesis by a 5-lipoxygenase inhibitor, garcinol. Nutr. Cancer 64, 1211–1218 (2012). · DOI
  59. Masullo, M. et al. Direct interaction of garcinol and related polyisoprenylated benzophenones of Garcinia cambogia fruits with the transcription factor STAT1 as a likely mechanism of their inhibitory effect on cytokine signaling pathways. J. Nat. Prod. 77, 543–549 (2014). · DOI
  60. Quideau, S., Deffieux, D., Douat-Casassus, C. & Pouységu, L. Plant polyphenols: chemical properties, biological activities, and synthesis. Angew. Chem. Int. Ed. Engl. 50, 586–621 (2011). · DOI
  61. Bowers, E. M. et al. Virtual ligand screening of the p300/CBP histone acetyltransferase: identification of a selective small molecule inhibitor. Chem. Biol. 17, 471–482 (2010). · DOI · Paper page
  62. Liu, Y. et al. Inhibition of p300 impairs FOXP3+ T regulatory cell function and promotes antitumor immunity. Nature Med. 19, 1173–1177 (2013). · DOI
  63. Webster, B. R. et al. Restricted mitochondrial protein acetylation initiates mitochondrial autophagy. J. Cell Sci. 126, 4843–4849 (2013). · DOI
  64. Johnson, S. C. et al. mTOR inhibition alleviates mitochondrial disease in a mouse model of Leigh syndrome. Science 342, 1524–1528 (2013). · DOI · Paper page
  65. Hamaï, A. & Codogno, P. New targets for acetylation in autophagy. Sci. Signal. 5, e29 (2012). · DOI
  66. Lin, Y. et al. Functional dissection of lysine deacetylases reveals that HDAC1 and p300 regulate AMPK. Nature 482, 251–255 (2012). · DOI
  67. Houtkooper, R. H. & Auwerx, J. Exploring the therapeutic space around NAD+. J. Cell Biol. 199, 205–209 (2012). · DOI
  68. Lee, I. H. et al. A role for the NAD-dependent deacetylase SIRT1 in the regulation of autophagy. Proc. Natl Acad. Sci. 105, 3374 (2008). · DOI
  69. Ou, X., Lee, M. R., Huang, X., Messina-Graham, S. & Broxmeyer, H. E. SIRT1 positively regulates autophagy and mitochondria function in embryonic stem cells under oxidative stress. Stem Cells 32, 1183–1194 (2014). · DOI
  70. Guarente, L. Calorie restriction and sirtuins revisited. Genes Dev. 27, 2072–2085 (2013). · DOI · Paper page
  71. Mercken, E. M. et al. SIRT1 but not its increased expression is essential for lifespan extension in caloric-restricted mice. Aging Cell 13, 193–196 (2014). · DOI
  72. Someya, S. et al. SIRT3 mediates reduction of oxidative damage and prevention of age-related hearing loss under caloric restriction. Cell 143, 802–812 (2010). · DOI · Paper page
  73. Fontana, L., Weiss, E. P., Villareal, D. T., Klein, S. & Holloszy, J. O. Long-term effects of calorie or protein restriction on serum IGF-1 and IGFBP-3 concentration in humans. Aging Cell 7, 681–687 (2008). · DOI
  74. Hubbard, B. P. et al. Evidence for a common mechanism of SIRT1 regulation by allosteric activators. Science 339, 1216–1219 (2013). · DOI · Paper page
  75. Park, S.-J. et al. Resveratrol ameliorates aging-related metabolic phenotypes by inhibiting cAMP phosphodiesterases. Cell 148, 421–433 (2012). · DOI
  76. Jimenez-Gomez, Y. et al. Resveratrol improves adipose insulin signaling and reduces the inflammatory response in adipose tissue of rhesus monkeys on high-fat, high-sugar diet. Cell. Metab. 18, 533–545 (2013). · DOI
  77. Pearson, K. J. et al. Resveratrol delays age-related deterioration and mimics transcriptional aspects of dietary restriction without extending life span. Cell. Metab. 8, 157–168 (2008). · DOI · Paper page
  78. Liu, K., Zhou, R., Wang, B. & Mi, M.-T. Effect of resveratrol on glucose control and insulin sensitivity: a meta-analysis of 11 randomized controlled trials. Am. J. Clin. Nutr. 99, 1510–1519 (2014). · DOI
  79. Fiori, J. L. et al. Resveratrol prevents β-cell dedifferentiation in nonhuman primates given a high-fat/high-sugar diet. Diabetes 62, 3500–3513 (2013). · DOI
  80. Yoshino, J. et al. Resveratrol supplementation does not improve metabolic function in nonobese women with normal glucose tolerance. Cell. Metab. 16, 658–664 (2012). · DOI
  81. Soare, A., Weiss, E. P., Holloszy, J. O. & Fontana, L. Multiple dietary supplements do not affect metabolic and cardio-vascular health. Aging 6, 149–157 (2013). · DOI
  82. Minor, R. K. et al. SRT1720 improves survival and healthspan of obese mice. Sci. Rep. 1, 70 (2011). · DOI
  83. Mitchell, S. J. et al. The SIRT1 activator SRT1720 extends lifespan and improves health of mice fed a standard diet. Cell Rep. 6, 836–843 (2014). · DOI
  84. Amat, R. et al. SIRT1 controls the transcription of the peroxisome proliferator-activated receptor-γ co-activator-1α (PGC1α) gene in skeletal muscle through the PGC1α autoregulatory loop and interaction with MyoD. J. Biol. Chem. 284, 21872–21880 (2009). · DOI
  85. Sinclair, D. A. & Guarente, L. Small-molecule allosteric activators of sirtuins. Annu. Rev. Pharmacol. Toxicol. 54, 363–380 (2014). · DOI
  86. Mouchiroud, L. et al. The NAD+/sirtuin pathway modulates longevity through activation of mitochondrial UPR and FOXO signaling. Cell 154, 430–441 (2013). · DOI · Paper page
  87. Ashrafian, H., Horowitz, J. D. & Frenneaux, M. P. Perhexiline. Cardiovasc. Drug Rev. 25, 76–97 (2007). · DOI
  88. Bordone, L. et al. SIRT1 transgenic mice show phenotypes resembling calorie restriction. Aging Cell 6, 759–767 (2007). · DOI · Paper page
  89. Price, N. L. et al. SIRT1 is required for AMPK activation and the beneficial effects of resveratrol on mitochondrial function. Cell. Metab. 15, 675–690 (2012). · DOI · Paper page
  90. Gao, P. et al. Overexpression of SIRT1 in vascular smooth muscle cells attenuates angiotensin II-induced vascular remodeling and hypertension in mice. J. Mol. Med. 92, 347–357 (2014). · DOI
  91. Timmers, S. et al. Calorie restriction-like effects of 30 days of resveratrol supplementation on energy metabolism and metabolic profile in obese humans. Cell. Metab. 14, 612–622 (2011). · DOI · Paper page
  92. Blum, C. A. et al. SIRT1 modulation as a novel approach to the treatment of diseases of aging. J. Med. Chem. 54, 417–432 (2011). · DOI
  93. Yao, T. P. et al. Gene dosage-dependent embryonic development and proliferation defects in mice lacking the transcriptional integrator p300. Cell 93, 361–372 (1998). · DOI
  94. Bedford, D. C. et al. Disrupting the CH1 domain structure in the acetyltransferases CBP and p300 results in lean mice with increased metabolic control. Cell. Metab. 14, 219–230 (2011). · DOI
  95. Mielgo-Ayuso, J. et al. Effects of dietary supplementation with epigallocatechin-3-gallate on weight loss, energy homeostasis, cardiometabolic risk factors and liver function in obese women: randomised, double-blind, placebo-controlled clinical trial. Br. J. Nutr. 111, 1263–1271 (2014). · DOI
  96. Mantelingu, K. et al. Specific inhibition of p300-HAT alters global gene expression and represses HIV replication. Chem. Biol. 14, 645–657 (2007). · DOI
  97. Eliseeva, E. D., Valkov, V., Jung, M. & Jung, M. O. Characterization of novel inhibitors of histone acetyltransferases. Mol. Cancer Ther. 6, 2391–2398 (2007). · DOI
  98. Mariño, G., Niso-Santano, M., Baehrecke, E. H. & Kroemer, G. Self-consumption: the interplay of autophagy and apoptosis. Nature Rev. Mol. Cell. Biol. 15, 81–94 (2014). · DOI · Paper page
  99. Mariño, G. et al. Longevity-relevant regulation of autophagy at the level of the acetylproteome. Autophagy 7, 647–649 (2011). · DOI
  100. Holmqvist, P.-H. & Mannervik, M. Genomic occupancy of the transcriptional co-activators p300 and CBP. Transcription 4, 18–23 (2013). · DOI
  101. Contreras, A. U. et al. Deacetylation of p53 induces autophagy by suppressing Bmf expression. J. Cell Biol. 201, 427–437 (2013). · DOI · Paper page
  102. Füllgrabe, J. et al. The histone H4 lysine 16 acetyltransferase hMOF regulates the outcome of autophagy. Nature 500, 468–471 (2013). · DOI
  103. Miller, R. A. et al. Rapamycin-mediated lifespan increase in mice is dose and sex dependent and metabolically distinct from dietary restriction. Aging Cell 13, 468–477 (2014). · DOI
  104. Anisimov, V. N. et al. Rapamycin increases lifespan and inhibits spontaneous tumorigenesis in inbred female mice. Cell Cycle 10, 4230–4236 (2011). · DOI
  105. Lamming, D. W. et al. Rapamycin-induced insulin resistance is mediated by mTORC2 loss and uncoupled from longevity. Science 335, 1638–1643 (2012). · DOI · Paper page
  106. Wilkinson, J. E. et al. Rapamycin slows aging in mice. Aging Cell 11, 675–682 (2012). · DOI · Paper page
  107. Delvecchio, M., Gaucher, J., Aguilar-Gurrieri, C., Ortega, E. & Panne, D. Structure of the p300 catalytic core and implications for chromatin targeting and HAT regulation. Nature Struct. Mol. Biol. 20, 1040–1046 (2013). · DOI
  108. Dominy, J., Puigserver, P. & Cantó, C. In vivo measurement of the acetylation state of sirtuin substrates as a proxy for sirtuin activity. Methods Mol. Biol. 1077, 217–237 (2013). · DOI
  109. Kepp, O., Galluzzi, L., Lipinski, M., Yuan, J. & Kroemer, G. Cell death assays for drug discovery. Nature Rev. Drug Discov. 10, 221–237 (2011). · DOI
  110. Coschigano, K. T., Clemmons, D., Bellush, L. L. & Kopchick, J. J. Assessment of growth parameters and life span of GHR/BP gene-disrupted mice. Endocrinology 141, 2608–2613 (2000). · DOI · Paper page
  111. Zhou, Y. et al. A mammalian model for Laron syndrome produced by targeted disruption of the mouse growth hormone receptor/binding protein gene (the Laron mouse). Proc. Natl Acad. Sci. USA 94, 13215–13220 (1997). · DOI
  112. Arum, O., Bonkowski, M. S., Rocha, J. S. & Bartke, A. The growth hormone receptor gene-disrupted mouse fails to respond to an intermittent fasting diet. Aging Cell 8, 756–760 (2009). · DOI
  113. Florez-McClure, M. L., Hohsfield, L. A., Fonte, G., Bealor, M. T. & Link, C. D. Decreased insulin-receptor signaling promotes the autophagic degradation of β-amyloid peptide in C. elegans. Autophagy 3, 569–580 (2007). · DOI
  114. Longo, V. D. Linking sirtuins, IGFI signaling, and starvation. Exp. Gerontol. 44, 70–74 (2009). · DOI
  115. Yuan, R. et al. Aging in inbred strains of mice: study design and interim report on median lifespans and circulating IGF1 levels. Aging Cell 8, 277–287 (2009). · DOI
  116. Levine, M. E. et al. Low protein intake is associated with a major reduction in IGF1, cancer, and overall mortality in the 65 and younger but not older population. Cell. Metab. 19, 407–417 (2014). · DOI · Paper page
  117. Phan, T. T. et al. Multi-centre experience on the use of perhexiline in chronic heart failure and refractory angina: old drug, new hope. Eur. J. Heart Fail. 11, 881–886 (2009). · DOI
  118. Abozguia, K. et al. Metabolic modulator perhexiline corrects energy deficiency and improves exercise capacity in symptomatic hypertrophic cardiomyopathy. Circulation 122, 1562–1569 (2010). · DOI
  119. Guay, C., Madiraju, S. R. M., Aumais, A., Joly, E. & Prentki, M. A role for ATP-citrate lyase, malic enzyme, and pyruvate/citrate cycling in glucose-induced insulin secretion. J. Biol. Chem. 282, 35657–35665 (2007). · DOI
  120. Cappello, A. R. et al. The mitochondrial citrate carrier (CIC) is present and regulates insulin secretion by human male gamete. Endocrinology 153, 1743–1754 (2012). · DOI
  121. Asghar, M. et al. Super CitriMax (HCA-SX) attenuates increases in oxidative stress, inflammation, insulin resistance, and body weight in developing obese Zucker rats. Mol. Cell. Biochem. 304, 93–99 (2007). · DOI
  122. Hanai, J.-I., Doro, N., Seth, P. & Sukhatme, V. P. ATP citrate lyase knockdown impacts cancer stem cells in vitro. Cell Death Dis. 4, e696 (2013). · DOI
  123. Zhao, Y., Huang, Z.-J., Rahman, M., Luo, Q. & Thorlacius, H. Radicicol, an HSP90 inhibitor, inhibits intestinal inflammation and leakage in abdominal sepsis. J. Surg. Res. 182, 312–318 (2013). · DOI
  124. He, Y. et al. Radicicol, a heat shock protein 90 inhibitor, inhibits differentiation and adipogenesis in 3T3-L1 preadipocytes. Biochem. Biophys. Res. Commun. 436, 169–174 (2013). · DOI
  125. Sonoda, H. et al. The protective effect of radicicol against renal ischemia — reperfusion injury in mice. J. Pharmacol. Sci. 112, 242–246 (2010). · DOI
  126. Conte, T. C. et al. Radicicol improves regeneration of skeletal muscle previously damaged by crotoxin in mice. Toxicon 52, 146–155 (2008). · DOI
  127. Griffin, T. M., Valdez, T. V. & Mestril, R. Radicicol activates heat shock protein expression and cardioprotection in neonatal rat cardiomyocytes. Am. J. Physiol. Heart Circ. Physiol. 287, H1081–H1088 (2004). · DOI
  128. Hatzivassiliou, G. et al. ATP citrate lyase inhibition can suppress tumor cell growth. Cancer Cell 8, 311–321 (2005). · DOI · Paper page
  129. Pearce, N. J. et al. The role of ATP citrate-lyase in the metabolic regulation of plasma lipids. Hypolipidaemic effects of SB-204990, a lactone prodrug of the potent ATP citrate-lyase inhibitor SB-201076. Biochem. J. 334, 113–119 (1998). · DOI
  130. Stuart, S. D. et al. A strategically designed small molecule attacks α-ketoglutarate dehydrogenase in tumor cells through a redox process. Cancer Metab. 2, 4 (2014). · DOI
  131. Zachar, Z. et al. Non-redox-active lipoate derivates disrupt cancer cell mitochondrial metabolism and are potent anticancer agents in vivo. J. Mol. Med. 89, 1137–1148 (2011). · DOI
  132. Lee, K. C. et al. Formation and anti-tumor activity of uncommon in vitro and in vivo metabolites of CPI-613, a novel anti-tumor compound that selectively alters tumor energy metabolism. Drug Metab. Lett. 5, 163–182 (2011). · DOI
  133. Kang, S.-K., Cha, S.-H. & Jeon, H.-G. Curcumin-induced histone hypoacetylation enhances caspase-3-dependent glioma cell death and neurogenesis of neural progenitor cells. Stem Cells Dev. 15, 165–174 (2006). · DOI
  134. Sunagawa, Y. et al. A natural p300-specific histone acetyltransferase inhibitor, curcumin, in addition to angiotensin-converting enzyme inhibitor, exerts beneficial effects on left ventricular systolic function after myocardial infarction in rats. Circ. J. 75, 2151–2159 (2011). · DOI
  135. Morimoto, T. et al. The dietary compound curcumin inhibits p300 histone acetyltransferase activity and prevents heart failure in rats. J. Clin. Invest. 118, 868–878 (2008).
  136. Marcu, M. G. et al. Curcumin is an inhibitor of p300 histone acetylatransferase. Med. Chem. 2, 169–174 (2006). · DOI
  137. Balasubramanyam, K. et al. Curcumin, a novel p300/CREB-binding protein-specific inhibitor of acetyltransferase, represses the acetylation of histone/nonhistone proteins and histone acetyltransferase-dependent chromatin transcription. J. Biol. Chem. 279, 51163–51171 (2004). · DOI
  138. Bimonte, S. et al. Curcumin inhibits tumor growth and angiogenesis in an orthotopic mouse model of human pancreatic cancer. BioMed Res. Int. 2013, 810423 (2013).
  139. Huang, M. T. et al. Inhibitory effects of dietary curcumin on forestomach, duodenal, and colon carcinogenesis in mice. Cancer Res. 54, 5841–5847 (1994).
  140. Rao, C. V., Rivenson, A., Simi, B. & Reddy, B. S. Chemoprevention of colon cancer by dietary curcumin. Ann. NY Acad. Sci. 768, 201–204 (1995). · DOI
  141. Sharma, R. A. et al. Pharmacodynamic and pharmacokinetic study of oral Curcuma extract in patients with colorectal cancer. Clin. Cancer Res. 7, 1894–1900 (2001).
  142. Seo, K.-I. et al. Effect of curcumin supplementation on blood glucose, plasma insulin, and glucose homeostasis related enzyme activities in diabetic db/db mice. Mol. Nutr. Food Res. 52, 995–1004 (2008). · DOI
  143. Liao, V. H.-C. et al. Curcumin-mediated lifespan extension in Caenorhabditis elegans. Mech. Ageing Dev. 132, 480–487 (2011). · DOI
  144. Suckow, B. K. & Suckow, M. A. Lifespan extension by the antioxidant curcumin in Drosophila melanogaster. Int. J. Biomed. Sci. 2, 402–405 (2006). · DOI
  145. Ryu, M.-J. et al. Natural derivatives of curcumin attenuate the Wnt/β-catenin pathway through down-regulation of the transcriptional coactivator p300. Biochem. Biophys. Res. Commun. 377, 1304–1308 (2008). · DOI
  146. Shakibaei, M. et al. Curcumin enhances the effect of chemotherapy against colorectal cancer cells by inhibition of NF-κB and Src protein kinase signaling pathways. PLoS ONE 8, e57218 (2013). · DOI
  147. Kubota, M. et al. Preventive effects of curcumin on the development of azoxymethane-induced colonic preneoplastic lesions in male C57BL/KsJ–db/db obese mice. Nutr. Cancer 64, 72–79 (2012). · DOI
  148. Jang, H.-J., Ridgeway, S. D. & Kim, J.-A. Effects of the green tea polyphenol epigallocatechin-3-gallate on high-fat diet-induced insulin resistance and endothelial dysfunction. Am. J. Physiol. Endocrinol. Metab. 305, E1444–E1451 (2013). · DOI
  149. Chen, Y.-K. et al. Effects of green tea polyphenol (–)-epigallocatechin-3-gallate on newly developed high-fat/Western-style diet-induced obesity and metabolic syndrome in mice. J. Agr. Food Chem. 59, 11862–11871 (2011). · DOI
  150. Rajendran, P., Ho, E., Williams, D. E. & Dashwood, R. H. Dietary phytochemicals, HDAC inhibition, and DNA damage/repair defects in cancer cells. Clin. Epigenet. 3, 4 (2011). · DOI
  151. Wu, Y. et al. Anacardic acid (6-pentadecylsalicylic acid) inhibits tumor angiogenesis by targeting Src/FAK/Rho GTPases signaling pathway. J. Pharmacol. Exp. Ther. 339, 403–411 (2011). · DOI
  152. Li, F. et al. Garcinol, a polyisoprenylated benzophenone modulates multiple proinflammatory signaling cascades leading to the suppression of growth and survival of head and neck carcinoma. Cancer Prev. Res. 6, 843–854 (2013). · DOI
  153. Arif, M. et al. Mechanism of p300 specific histone acetyltransferase inhibition by small molecules. J. Med. Chem. 52, 267–277 (2009). · DOI
  154. Mai, A. et al. Small-molecule inhibitors of histone acetyltransferase activity: identification and biological properties. J. Med. Chem. 49, 6897–6907 (2006). · DOI
  155. Chimenti, F. et al. A novel histone acetyltransferase inhibitor modulating GCN5 network: cyclopentylidene-[4-(4′-chlorophenyl)thiazol-2-yl)hydrazone. J. Med. Chem. 52, 530–536 (2009). · DOI
  156. Jara, J. A. et al. Antiproliferative and uncoupling effects of delocalized, lipophilic, cationic gallic acid derivatives on cancer cell lines. Validation in vivo in singenic mice. J. Med. Chem. 57, 2440–2454 (2014). · DOI
  157. Lu, Y. et al. Gallic acid suppresses cell viability, proliferation, invasion and angiogenesis in human glioma cells. Eur. J. Pharmacol. 641, 102–107 (2010). · DOI
  158. Kim, M.-J. et al. Gallic acid, a histone acetyltransferase inhibitor, suppresses β-amyloid neurotoxicity by inhibiting microglial-mediated neuroinflammation. Mol. Nutr. Food Res. 55, 1798–1808 (2011). · DOI
  159. Lissa, D. et al. Resveratrol and aspirin eliminate tetraploid cells for anticancer chemoprevention. Proc. Natl Acad. Sci. USA 111, 3020–3025 (2014). · DOI
  160. Lu, S.-P., Kato, M. & Lin, S.-J. Assimilation of endogenous nicotinamide riboside is essential for calorie restriction-mediated life span extension in Saccharomyces cerevisiae. J. Biol. Chem. 284, 17110–17119 (2009). · DOI · Paper page
  161. Dong, J. et al. Quercetin reduces obesity-associated ATM infiltration and inflammation in mice: a mechanism including AMPKα1/SIRT1. J. Lipid Res. 55, 363–374 (2014). · DOI
  162. Pratheeshkumar, P. et al. Quercetin inhibits angiogenesis mediated human prostate tumor growth by targeting VEGFR2 regulated AKT/mTOR/P70S6K signaling pathways. PLoS ONE 7, e47516 (2012). · DOI
  163. Angst, E. et al. The flavonoid quercetin inhibits pancreatic cancer growth in vitro and in vivo. Pancreas 42, 223–229 (2013). · DOI
  164. Yum, S. et al. Piceatannol, a hydroxystilbene natural product, stabilizes HIF1α protein by inhibiting HIF prolyl hydroxylase. Eur. J. Pharmacol. 699, 124–131 (2013). · DOI
  165. Kinoshita, Y. et al. Effect of long-term piceatannol treatment on eNOS levels in cultured endothelial cells. Biochem. Biophys. Res. Commun. 430, 1164–1168 (2013). · DOI
  166. Kwon, J. Y. et al. Piceatannol, natural polyphenolic stilbene, inhibits adipogenesis via modulation of mitotic clonal expansion and insulin receptor-dependent insulin signaling in early phase of differentiation. J. Biol. Chem. 287, 11566–11578 (2012). · DOI
  167. Minakawa, M., Miura, Y. & Yagasaki, K. Piceatannol, a resveratrol derivative, promotes glucose uptake through glucose transporter 4 translocation to plasma membrane in L6 myocytes and suppresses blood glucose levels in type 2 diabetic model db/db mice. Biochem. Biophys. Res. Commun. 422, 469–475 (2012). · DOI

Cited by

Sorted by citations

Metadata

Authors
Madeo, F., Pietrocola, F., Eisenberg, T., & Kroemer, G.
Venue
Nature Reviews Drug Discovery
Published
2014-09-12
Volume
13
Issue
10
Pages
727-740
ISSN
  • 1474-1776
  • 1474-1784
Cited by
245
References
36
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review